External Validation of the ASSURE Model for Predicting Oncological Outcomes After Resection of High-risk Renal Cell Carcinoma (RESCUE Study: UroCCR 88)

External Validation of the ASSURE Model for Predicting Oncological Outcomes After Resection of High-risk Renal Cell Carcinoma (RESCUE Study: UroCCR 88)

A prognostic model based on the population of the ASSURE phase 3 trial has recently been described. The ASSURE model stratifies patients into risk groups to predict survival after surgical resection of intermediate- and high-risk localised kidney cancer. We evaluated this model in an independent coh...

Full description

Bibliographic Details
Main Authors: Zine-Eddine Khene, Alessandro Larcher, Jean-Christophe Bernhard, Nicolas Doumerc, Idir Ouzaid, Umberto Capitanio, François-Xavier Nouhaud, Romain Boissier, Nathalie Rioux-Leclercq, Alexandre De La Taille, Philippe Barthelemy, Francesco Montorsi, Morgan Rouprêt, Pierre Bigot, Karim Bensalah
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:European Urology Open Science
Subjects:
Kidney cancer
Prognosis
Survival
Risk groups
Nephrectomy
External validation
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168321006765

Internet

http://www.sciencedirect.com/science/article/pii/S2666168321006765

Similar Items